Home » Topics » BioWorld Science

BioWorld Science
RSS

Sanofi completes acquisition of Ablynx

June 19, 2018

Clover initiates phase I trial of SCB-313 for malignant ascites

June 19, 2018

Cognition Therapeutics initiates SPARC trial of Elayta in Alzheimer's disease

June 19, 2018

MXRA8, a drug-targetable receptor for chikunguya and other arthritogenic alphaviruses

June 19, 2018

Rhythm announces new topline clinical data for setmelanotide in rare genetic disorders of obesity

June 19, 2018

Agios initiates phase III ACTIVATE study of AG-348 in pyruvate kinase deficiency

June 19, 2018

Catalyst offers update from Cohort 6 in phase I/II trial of CB-2679d for hemophilia B

June 19, 2018

FDA grants fast track designation to mirvetuximab soravtansine in platinum-resistant ovarian cancer

June 19, 2018

Forge Therapeutics LpxC inhibitor shows activity in vitro, in vivo and in combination

June 19, 2018

Phase II results for talimogene laherparepvec plus pembrolizumab in patients with sarcoma

June 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...